Curis | CRIS - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Alaunos Therapeutics USD 1.01M 175K 2026-03
Amgen USD 11.69B 6.9B 2026-06
AstraZeneca USD 12.22B 4.04B 2026-06
Bayer EUR 10.04B 168M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
CSL USD 5.7B 2.82B 2025-12
Curis USD 11.52M 2.5M 2026-03
Eli Lilly USD 10.52B 496M 2026-06
Exelixis USD 380.28M 20.8M 2026-06
Gilead Sciences USD 3.95B 19.57B 2026-06
GlaxoSmithKline GBP 5.8B 468M 2026-06
Incyte USD 973.64M 4.65B 2026-06
Merck USD 15.77B 2.4B 2026-06
Novartis USD 10.2B 912M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 9.92B 607M 2026-06
Takeda JPY 1.02T 89.68B 2026-06
TG Therapeutics USD 218.66M 48.54M 2026-06
Verastem USD 63.57M 4.56M 2026-03